Coiled Therapeutics annual ebitda
2022
2023
2024
2025
Coiled Therapeutics EBITDA Growth & History (COIL)
Coiled Therapeutics's calculated EBITDA was −£3.4M for fiscal 2025.
View full Coiled Therapeutics company overviewCoiled Therapeutics annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −£3.4M | −£2.2M | — |
| 2024 | 2024-12-31 | −£1.2M | £763,977 | — |
| 2023 | 2023-12-31 | −£1.9M | −£293,982 | — |
| 2022 | 2022-12-31 | −£1.6M | — | — |
Coiled Therapeutics ebitda trends
Between the periods ended 2022-12-31 and 2025-12-31, Coiled Therapeutics's ebitda decreased from −£1.6M to −£3.4M, a change of −£1.7M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Coiled Therapeutics source filings ↗Community posts
Coiled reports £3.85 million interim loss after oncology transformation
Coiled Therapeutics ($COIL) reported a first-half loss before tax of £3.85 million, compared with £0.53 million a year earlier, following its shift into clinical-stage oncology. Operating activities consumed £2.85 million of cash versus £0. ...
